Healthcare -
Biotechnology - NASDAQ - US
$ 0.7099
2.16 %
$ 31.2 M
Market Cap
-0.46
P/E
XLO - STOCK-BASED COMPENSATION
Stock-based Compensation XLO - Xilio Therapeutics, Inc.
7.38 M
LAST VALUE
22.02%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR